Molecular pathology of Lynch syndrome.

The Journal of Pathology
Guia CerretelliIan M Frayling

Abstract

Lynch syndrome (LS) is characterised by predisposition to colorectal, endometrial, and other cancers and is caused by inherited pathogenic variants affecting the DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2. It is probably the most common predisposition to cancer, having an estimated prevalence of between 1/100 and 1/180. Resources such as the International Society for Gastrointestinal Hereditary Cancer's MMR gene variant database, the Prospective Lynch Syndrome Database (PLSD), and the Colon Cancer Family Register (CCFR), as well as pathological and immunological studies, are enabling advances in the understanding of LS. These include defined criteria by which to interpret gene variants, the function of MMR in the normal control of apoptosis, definition of the risks of the various cancers, and the mechanisms and pathways by which the colorectal and endometrial tumours develop, including the critical role of the immune system. Colorectal cancers in LS can develop along three pathways, including flat intramucosal lesions, which depend on the underlying affected MMR gene. This gives insights into the limitations of colonoscopic surveillance and highlights the need for other forms of anti-cancer prophylaxis in LS. Fi...Continue Reading

References

Sep 1, 1985·The British Journal of Dermatology·H T LynchJ F Lynch
Nov 1, 1968·Archives of Dermatology·D Torre
Mar 30, 1995·The New England Journal of Medicine·S R HamiltonB Tetu
Aug 12, 1993·Annals of the New York Academy of Sciences·W F BodmerJ G Bodmer
Jan 1, 1996·Annual Review of Biochemistry·P Modrich, R Lahue
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·I P TomlinsonW F Bodmer
Nov 14, 1997·International Journal of Cancer. Journal International Du Cancer·M AarnioH J Järvinen
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·N J ToftA R Clarke
Jun 16, 1999·Gut·I M Frayling
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M NilbertA Johnson
Dec 14, 1999·The American Journal of Pathology·A LoukolaL A Aaltonen
Feb 13, 2001·The American Journal of Pathology·J AlexanderS R Hamilton
Jun 8, 2001·International Journal of Cancer. Journal International Du Cancer·M LinnebacherM von Knebel Doeberitz
Jun 8, 2001·International Journal of Cancer. Journal International Du Cancer·S M WoernerM von Knebel Doeberitz
Nov 1, 2001·Proceedings of the National Academy of Sciences of the United States of America·I SaeterdalG Gaudernack
Jun 11, 2002·American Journal of Physiology. Cell Physiology·Christina L ChangC Richard Boland
Nov 26, 2002·Nature Genetics·Kevin D BrownR Baskaran
Apr 17, 2003·Molecular and Cellular Biology·Valia T MihaylovaPeter M Glazer
Sep 1, 1958·British Journal of Cancer·C E DUKES, H J BUSSEY
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Jul 29, 2004·DNA Repair·Lovorka StojicJosef Jiricny
Feb 1, 2005·Annals of the New York Academy of Sciences·Robin G Lorenz, Rodney D Newberry
Nov 16, 2005·Gastroenterology·Megan HitchinsRobyn Ward
Mar 22, 2006·Nature Immunology·Danielle L DraytonNancy H Ruddle
Mar 1, 2007·Journal of Medical Genetics·H F A VasenJ Wijnen
Mar 22, 2007·International Journal of Cancer. Journal International Du Cancer·Matthias KloorMagnus von Knebel Doeberitz
May 19, 2007·Cancer Research·Masanobu TakahashiChikashi Ishioka
Jun 5, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Brenda DiergaardeEllen Kampman
Feb 14, 2008·Journal of the National Cancer Institute·Christopher D SouthAlbert de la Chapelle
Feb 20, 2008·Familial Cancer·Brindusa TrutaJonathan P Terdiman
Mar 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael D WalshAndreas Obermair
Apr 15, 2008·Mechanisms of Ageing and Development·Peggy Hsieh, Kazuhiko Yamane
Jul 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annelie LiljegrenD Timothy Bishop

❮ Previous
Next ❯

Citations

Apr 30, 2020·The Journal of Pathology·C Simon HerringtonPhilip J Coates
Oct 14, 2020·Journal of Clinical Pathology·Manon SuerinkUNKNOWN PALGA-group collaborators
Feb 14, 2021·Journal of Huntington's Disease·Ravi R Iyer, Anna Pluciennik
Nov 17, 2020·Frontiers in Oncology·Shiqin LiHan-Xiang An
Apr 27, 2021·Oral Diseases·Gleyson Kleber do Amaral-SilvaPablo Agustin Vargas
May 28, 2021·BMC Cancer·Alice TalbotDavid Gallagher
May 19, 2021·Cancer Research·Prashant V BommiEduardo Vilar
May 26, 2021·Translational Oncology·Alessandro OttaianoGuglielmo Nasti
Jun 15, 2021·Current Oncology Reports·Danielle M Pastor, Jeffrey Schlom
Jul 22, 2021·NPJ Precision Oncology·C B WestphalenF de Braud
Feb 6, 2021·Journal of the National Comprehensive Cancer Network : JNCCN·Agata A BielskaRona Yaeger
Aug 28, 2021·Virchows Archiv : an International Journal of Pathology·Ning WangXiaowei Zhu
Sep 21, 2021·The Journal of Pathology·Guia CerretelliMark J Arends

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Familial Cancer
Albert de la Chapelle
Journal of Pediatric Gastroenterology and Nutrition
Sherry C HuangSteven H Erdman
© 2021 Meta ULC. All rights reserved